ADR,SEQ,PT,HLT,HLGT,SOC_ABBREV,FATAL_YN
1,1,Renal failure,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
2,1,Clostridium difficile infection,Clostridia infections,Bacterial infectious disorders,Infec,N
3,1,Pathogen resistance,Infections NEC,Infections - pathogen unspecified,Infec,Y
4,1,Critical illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
4,2,Minimum inhibitory concentration increased,Microbiology and serology tests NEC,Microbiology and serology investigations,Inv,N
4,3,Renal tubular acidosis,Nephropathies and tubular disorders NEC,Nephropathies,Renal,N
5,1,Clostridium difficile infection,Clostridia infections,Bacterial infectious disorders,Infec,N
5,2,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
6,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,Y
7,1,Pancytopenia,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
8,1,Glomerular filtration rate abnormal,Renal function analyses,Renal and urinary tract investigations and urinalyses,Inv,N
8,2,Renal impairment,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
9,1,Renal impairment,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
10,1,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
10,2,Pathogen resistance,Infections NEC,Infections - pathogen unspecified,Infec,Y
10,3,Pneumonia pseudomonal,Pseudomonal infections,Bacterial infectious disorders,Infec,N
11,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
